Investigating the effect of finasteride and zinc supplement on hair loss after covid-19 infection

Comparison of the effect of zinc supplement along with finasteride and zinc supplement alone in the treatment of patients with hair loss and a history of covid-19 infection

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

IRCT

Registry ID

IRCT20230531058350N1

Enrollment

Registered

2023-06-13

Start date

2023-06-10

Completion date

Unknown

Last updated

2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hair loss. Nonscarring hair loss, unspecified

Interventions

Intervention 1: Intervention group: For three months, receiving one finasteride 5 mg tablet after breakfast and one zinc sulfate tablet containing 10 mg zinc elemental after lunch. Intervention 2: Int

Eligibility

Sex/Gender

All

Age

20 Years to 55 Years

Inclusion criteria

Inclusion criteria: All those who have been infected with Covid-19 for more than 6 months Noticeable hair loss

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Determining the comparative effect of zinc supplementation along with finasteride and zinc supplementation alone on the treatment of patients with hair loss after contracting the covid-19 disease. Timepoint: Three months after the intervention. Method of measurement: The opinion of two dermatologist separately.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHoda Ghoreshi Rad

Islamic Azad University

drghoreishirad@gmail.com+98 21 3334 8036

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026